ℹ️
🇬🇧
Search
Search for publications relevant for "CD38"
CD38
Publication
Class
Person
Publication
Programmes
Export current view
publication
The expression of CD38 ADP-ribosyl cyclase extoenzyme in immune cells of cardiac surgical patients
2008 |
First Faculty of Medicine
publication
CD38 antigen as a marker for immunological follow-up in HIV-positive patients
2004 |
First Faculty of Medicine
publication
CD38 antigen as a marker for immunological follow-up in HIV-positive patients
2004 |
Faculty of Physical Education and Sport
publication
The expression of CD38 ADP-ribosyl cyclase extoenzyme in immune cells of cardiac surgical patients
2008 |
Faculty of Medicine in Hradec Králové
publication
Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies
1993 |
Second Faculty of Medicine
publication
A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS
2021 |
Second Faculty of Medicine
publication
CD38: A target in relapsed/refractory acute lymphoblastic leukemia-Limitations in treatment and diagnostics
2022 |
Second Faculty of Medicine
publication
The expression of CD38 ADP-ribosyl cyclase extoenzyme in immune cells of cardiac surgical patients
2008 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University
publication
Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
2022 |
First Faculty of Medicine
publication
Longitudinal study of density of expression of CD38 antigen on CD8+ cells in HIV/AIDS patients treated with HAART
Publication without faculty affiliation
publication
The use of CD38+ antigen expression on CD8+ T-lymphocytes as a marker of HIV-1 infection
Publication without faculty affiliation
publication
Risk factors in chronic lymphocytic leukemia, validation of flow cytometric detection using RT-PCR and immunohistochemistry
2009 |
Third Faculty of Medicine
publication
Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia
2010 |
First Faculty of Medicine
publication
Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
2022 |
First Faculty of Medicine
publication
Expression of CD38 antigen on CD8+ T lymphocytes in HIV-1-infcted adults: the Czech prospective study
Publication without faculty affiliation
publication
Longitudinal study of density of expression of activation markers in HIV/AIDS patients
Publication without faculty affiliation
publication
CD38 expression on CD8(+) T cells in human immunodeficiency virus 1-positive adults treated with HAART
2003 |
First Faculty of Medicine
publication
Biological prognostic markers in chronic lymphocytic leukemia
2009 |
Faculty of Medicine in Hradec Králové
publication
The expanded CD19(+)IgM(+)CD27(-)CD21(low)CD38(low)CD24(-)B cell population in CVID patients shows the signs of antigen-driven selection and affinity maturation
2009 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Toxic Shock Syndrome and Persistent Immune Activation in an HIV-Positive Patient
2013 |
First Faculty of Medicine
publication
Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization
2009 |
First Faculty of Medicine
publication
Isatuximab for the treatment of relapsed/refractory multiple myeloma
2020 |
First Faculty of Medicine
publication
Biological prognostic markers in chronic lymphocytic leukemia
2009 |
First Faculty of Medicine
publication
Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta
2016 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis
2022 |
First Faculty of Medicine
publication
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
2022 |
First Faculty of Medicine
publication
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
2020 |
First Faculty of Medicine
publication
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
2018 |
First Faculty of Medicine
publication
The significance of selected protnostic markers for monitoring of multiple myeloma activity
2001 |
Faculty of Medicine in Hradec Králové
publication
Antiretroviral treatment of HIV infection does not influence HIV-specific immunity but has an impact on Non-specific immune activation
2011 |
First Faculty of Medicine